Denosumab compared with zoledronic acid on renal function in the treatment of myeloma bone disease
EULAR 2020 - Speaker interview: Delayed denosumab injections and fractures risk on osteoporosis
Prolia Side Effects
Bone Targeted Agents in Metastatic Prostate Cancer: Denosumab, Bisphosphonates and Radium-223
Optimal Patient Selection for Denosumab in Giant Cell Tumor of Bone
Denosumab is a human monoclonal antibody for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone.
Explore contextually related video stories in a new eye-catching way. Try Combster now!
Medical condition treated
Contraindications and interactions
Mechanism of action